SCHEMBL887222

SCHEMBL887222

O=C[C@H]1CC[C@H](C=O)CC1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 2/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL887195 1.00 ADH1A (0.32) ADH1AADH1BADH1C
SCHEMBL823159 1.00 ADH1A (0.32) ADH1AADH1BADH1C
SCHEMBL4848 1.00
SCHEMBL5118751 0.96
Hydrochloric Acid SCHEMBL529771 0.96
Hydrochloric Acid SCHEMBL15129546 0.96
Hydrochloric Acid SCHEMBL529536 0.96
SCHEMBL212950 0.96
SCHEMBL25423954 0.92
SCHEMBL22657699 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114381-A Blend and coating containing polyphenol alcoxylates 树脂材料集团公司 2019-08-09 CN claimed
EP-2876137-B1 Binder compositions of aliphatic or cycloaliphatic dicarboxaldehydes and resorcinol ROHM & HAAS (US) 2019-08-07 EP claimed
WO-2019142208-A1 AMBIENT TEMPERATURE CURABLE NON-ISOCYANATE POLYHYDROXYALKYLURETHANE MOIETIES WITH ALDEHYDE CROSS LINKER Asian Paints Ltd. (IN) 2019-07-25 WO claimed
EP-2200957-B2 HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-09-14 EP claimed
EP-2200957-B1 HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-26 EP claimed
US-8304583-B2 Hydrogenation of aliphatic dialdehydes to aliphatic diols DOW GLOBAL TECHNOLOGIES LLC 2012-11-06 US claimed
US-20110098514-A1 HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2011-04-28 US claimed
EP-1204623-A2 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2002-05-15 EP claimed
US-6252121-B1 SEPARATION OF CYCLIC REACTANTS, CORRESPONDING PRODUCTS, NONPOLAR SOLVENT, ORGANOPHOSPHORUS LIGANDS AND CATALYST COMPLEX MATERIALS FROM MULTIPHASE REACTION PRODUCT FLUID HAVING POLAR AND NONPOLAR PHASES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2001-06-26 US claimed
WO-2001007382-A2 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2001-02-01 WO claimed
US-12522737-B2 Crosslinkable flame-retardant coating composition SWIMC LLC (US) 2026-01-13 US disclosed
EP-3114164-B1 LOWER TEMPERATURE CURE COATING COMPOSITIONS KING INDUSTRIES INC (US) 2025-07-02 EP disclosed
CN-114072470-B Crosslinkable flame retardant coating composition SWIMC有限公司 2024-09-06 CN disclosed
CN-114231507-B Choline Arthrobacter choline oxidase mutant and application thereof 无锡阿科力科技股份有限公司 2023-11-14 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-1204623-A2 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2002-05-15 EP disclosed
US-6252121-B1 SEPARATION OF CYCLIC REACTANTS, CORRESPONDING PRODUCTS, NONPOLAR SOLVENT, ORGANOPHOSPHORUS LIGANDS AND CATALYST COMPLEX MATERIALS FROM MULTIPHASE REACTION PRODUCT FLUID HAVING POLAR AND NONPOLAR PHASES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2001-06-26 US disclosed
WO-2001007382-A2 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2001-02-01 WO disclosed
US-5670493-A ANGIOGENESIS INHIBITORS ADIR ET COMPAGNIE (FR) 1997-09-23 US disclosed
EP-0754693-A2 Novel aminophenylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1997-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098514-A1 HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS ADH1C, ADH1A, DHCR24 ADH1A 2/4885ADH1B 18/4885ADH1C 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.